Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Plus Pembrolizumab and Chemotherapy in CK5/6-High Advanced Intrahepatic Cholangiocarcinoma
NCT07632235Phase 2Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in intrahepatic cholangiocarcinoma (ICC), sponsored by Shanghai Sixth People's Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
celecoxib oral solution
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT07632235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07632235.